Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gennaro Musi

Showing results (181-190 of 266) with videos related to

Pageof 27
Sort By:
BMC Cancer|September 11, 2019
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)Giulia Marvaso, Delia Ciardo, Giulia Corrao, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|September 12, 2025
The need for novel biomarkers in prostate cancer: a UrOP perspectiveGuglielmo Mantica, Stefano Alba, Andrea Alfarone, et al.
Urologic Oncology|February 22, 2025
Sex-related differences in response to neoadjuvant and adjuvant chemotherapy in urothelial carcinoma of urinary bladder treated with radical cystectomyMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
Radiology|November 21, 2023
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical ProstatectomyStefano Luzzago, Alberto Colombo, Francesco A Mistretta, et al.
BJU International|October 23, 2021
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading ratesStefano Luzzago, Mattia Luca Piccinelli, Francesco A Mistretta, et al.
Annals of Surgical Oncology|September 6, 2025
ASO Visual Abstract: The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary DiversionFederico Polverino, Andrea Marmiroli, Mattia Longoni, et al.
Clinical Genitourinary Cancer|February 11, 2017
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph NodesBarbara Alicja Jereczek-Fossa, Giuseppe Fanetti, Cristiana Fodor, et al.
European Urology Open Science|July 13, 2023
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell CarcinomaMattia L Piccinelli, Stefano Tappero, Cristina Cano Garcia, et al.
Annals of Surgical Oncology|August 28, 2025
ASO Author Reflections: Chronic Liver Disease and Radical Cystectomy: Uncovering a Hidden Risk FactorFederico Polverino, Andrea Marmiroli, Mattia Longoni, et al.
Pageof 27

Showing results (181-190 of 266) with videos related to

Sort By:
Pageof 27
BMC Cancer|September 11, 2019
Radioablation +/- hormonotherapy for prostate cancer oligorecurrences (Radiosa trial): potential of imaging and biology (AIRC IG-22159)Giulia Marvaso, Delia Ciardo, Giulia Corrao, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|September 12, 2025
The need for novel biomarkers in prostate cancer: a UrOP perspectiveGuglielmo Mantica, Stefano Alba, Andrea Alfarone, et al.
Urologic Oncology|February 22, 2025
Sex-related differences in response to neoadjuvant and adjuvant chemotherapy in urothelial carcinoma of urinary bladder treated with radical cystectomyMario de Angelis, Carolin Siech, Letizia Maria Ippolita Jannello, et al.
Life (Basel, Switzerland)|July 27, 2024
Image-Guided Stereotactic Body Radiotherapy on Detectable Prostate Bed Recurrence after Prostatectomy in RT-Naïve PatientsRiccardo Santamaria, Mattia Zaffaroni, Maria Giulia Vincini, et al.
Radiology|November 21, 2023
Multiparametric MRI-based 5-year Risk Prediction Model for Biochemical Recurrence of Prostate Cancer after Radical ProstatectomyStefano Luzzago, Alberto Colombo, Francesco A Mistretta, et al.
BJU International|October 23, 2021
Repeat MRI during active surveillance: natural history of prostatic lesions and upgrading ratesStefano Luzzago, Mattia Luca Piccinelli, Francesco A Mistretta, et al.
Annals of Surgical Oncology|September 6, 2025
ASO Visual Abstract: The Effect of Chronic Liver Disease on Adverse In-Hospital Outcomes after Radical Cystectomy and Ileal Conduit Urinary DiversionFederico Polverino, Andrea Marmiroli, Mattia Longoni, et al.
Clinical Genitourinary Cancer|February 11, 2017
Salvage Stereotactic Body Radiotherapy for Isolated Lymph Node Recurrent Prostate Cancer: Single Institution Series of 94 Consecutive Patients and 124 Lymph NodesBarbara Alicja Jereczek-Fossa, Giuseppe Fanetti, Cristiana Fodor, et al.
European Urology Open Science|July 13, 2023
Assessment of the VENUSS and GRANT Models for Individual Prediction of Cancer-specific Survival in Surgically Treated Nonmetastatic Papillary Renal Cell CarcinomaMattia L Piccinelli, Stefano Tappero, Cristina Cano Garcia, et al.
Annals of Surgical Oncology|August 28, 2025
ASO Author Reflections: Chronic Liver Disease and Radical Cystectomy: Uncovering a Hidden Risk FactorFederico Polverino, Andrea Marmiroli, Mattia Longoni, et al.
Pageof 27